BlackRock’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.33M Buy
4,638,243
+325,605
+8% +$414K ﹤0.01% 3799
2025
Q4
$4.7M Buy
4,312,638
+643,346
+18% +$719K ﹤0.01% 3858
2025
Q3
$3.71M Buy
3,669,292
+50,969
+1% +$55.7K ﹤0.01% 3904
2025
Q2
$4.16M Buy
3,618,323
+3,591,013
+13,149% +$4.64M ﹤0.01% 3849
2025
Q1
$40.7K Hold
27,310
﹤0.01% 4955
2024
Q4
$22.4K Hold
27,310
﹤0.01% 5088
2024
Q3
$22.3K Hold
27,310
﹤0.01% 4927
2024
Q2
$22.4K Sell
27,310
-24,336
-47% -$20.6K ﹤0.01% 4998
2024
Q1
$41.8K Buy
51,646
+28,193
+120% +$36.6K ﹤0.01% 4909
2023
Q4
$33.1K Sell
23,453
-288
-1% -$380 ﹤0.01% 5025
2023
Q3
$27.8K Sell
23,741
-2,563
-10% -$3.72K ﹤0.01% 5096
2023
Q2
$36.6K Buy
26,304
+7,448
+39% +$11.2K ﹤0.01% 5122
2023
Q1
$26.4K Buy
18,856
+618
+3% +$856 ﹤0.01% 5220
2022
Q4
$24.8K Buy
18,238
+412
+2% +$741 ﹤0.01% 5350
2022
Q3
$28K Sell
17,826
-5,115
-22% -$12.7K ﹤0.01% 5460
2022
Q2
$52K Sell
22,941
-44,624
-66% -$99.1K ﹤0.01% 5401
2022
Q1
$227K Buy
67,565
+10,636
+19% +$38.9K ﹤0.01% 5075
2021
Q4
$305K Buy
+56,929
New +$462K ﹤0.01% 5007

Other funds holding LUCD